[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "LA Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 54, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 617224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Chaturvedi Ph.D.", "age": 65, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 419420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 47, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 469420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Albert  Agro Ph.d.", "age": 59, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 461099, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.25, "open": 1.27, "dayLow": 1.23, "dayHigh": 1.2799, "regularMarketPreviousClose": 1.25, "regularMarketOpen": 1.27, "regularMarketDayLow": 1.23, "regularMarketDayHigh": 1.2799, "payoutRatio": 0.0, "beta": -1.828, "trailingPE": 0.03145282, "forwardPE": -0.47908744, "volume": 41696, "regularMarketVolume": 41696, "averageVolume": 253701, "averageVolume10days": 352700, "averageDailyVolume10Day": 352700, "bid": 1.24, "ask": 0.0, "bidSize": 2, "askSize": 0, "marketCap": 3145968, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 30.43, "fiftyDayAverage": 1.5306, "twoHundredDayAverage": 6.87368, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -474744, "profitMargins": 0.0, "floatShares": 2140959, "sharesOutstanding": 2496800, "sharesShort": 128877, "sharesShortPriorMonth": 60577, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.051599998, "heldPercentInsiders": 0.00018999999, "heldPercentInstitutions": 0.00204, "shortRatio": 0.88, "shortPercentOfFloat": 0.051599998, "impliedSharesOutstanding": 2516940, "bookValue": 2.294, "priceToBook": 0.54925895, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -11277000, "trailingEps": 40.06, "forwardEps": -2.63, "lastSplitFactor": "1:17", "lastSplitDate": 1740355200, "enterpriseToEbitda": 0.051, "52WeekChange": -0.85525703, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 1.26, "targetHighPrice": 34.0, "targetLowPrice": 10.0, "targetMeanPrice": 22.0, "targetMedianPrice": 22.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 3281000, "totalCashPerShare": 1.532, "ebitda": -9387000, "totalDebt": 108000, "quickRatio": 1.181, "currentRatio": 1.414, "debtToEquity": 8.963, "returnOnAssets": -1.3603799, "returnOnEquity": -4.67949, "freeCashflow": -4757375, "operatingCashflow": -8144000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "GRI Bio, Inc.", "marketState": "CLOSED", "longName": "GRI Bio, Inc.", "postMarketChangePercent": -0.01587565, "postMarketPrice": 1.2598, "postMarketChange": -0.00020003319, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.23 - 1.2799", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 253701, "fiftyTwoWeekLowChange": 0.15999997, "fiftyTwoWeekLowChangePercent": 0.14545451, "fiftyTwoWeekRange": "1.1 - 30.43", "fiftyTwoWeekHighChange": -29.17, "fiftyTwoWeekHighChangePercent": -0.9585935, "fiftyTwoWeekChangePercent": -85.5257, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 40.06, "epsForward": -2.63, "epsCurrentYear": -4.045, "priceEpsCurrentYear": -0.31149566, "fiftyDayAverageChange": -0.27059996, "corporateActions": [], "postMarketTime": 1754695539, "regularMarketTime": 1754683201, "exchange": "NCM", "messageBoardId": "finmb_136941170", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.799999, "regularMarketPrice": 1.26, "fiftyDayAverageChangePercent": -0.1767934, "twoHundredDayAverageChange": -5.61368, "twoHundredDayAverageChangePercent": -0.81669205, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612967400000, "displayName": "GRI Bio", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]